TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
XGN

Exagen Inc

Healthcare · Diagnostics & Research

8.70$ +2.2% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement XGN
Line item 2012 2013 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +229.9% +281.8% +53.9% +49.4% +21.0% +24.5% +3.9% +15.1% -5.7% +15.3% +5.9% +19.7%
– +43.4% +143.3% +38.5% +48.3% +8.8% +22.3% -12.0% +24.3% +17.6% -4.6% -2.4% +23.3%
– – +2,023.6% +76.1% +50.6% +34.7% +26.5% +17.8% +9.0% -23.0% +38.0% +12.4% +17.2%
– -15.0% +43.5% +6.2% +13.5% +37.0% +2.4% +64.0% +102.8% +36.5% -50.7% +10.5% +16.4%
– +35.2% +112.8% +13.9% +10.1% +4.3% +48.3% +31.8% +19.9% +14.4% -6.3% -13.0% +16.6%
– +26.3% +104.5% +15.0% +7.8% +6.7% +40.7% +31.5% +27.5% +30.2% -22.4% -10.6% +13.1%
– – – – – – – – – – – – –
– +103.2% +212.5% +53.0% -34.5% -2.7% +21.7% -26.5% +2.3% -6.7% -4.6% -4.3% +93.3%
– – – – – – – – – – – – –
– +0.0% -131.0% – -317.0% – -56.9% -416.0% – -261.1% – -63.6% +325.0%
– – – – – – – – – – – – –
– – – – – – – – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?